Mayo Clinic Laboratories > BioPharma Diagnostics > Testing > Infectious diseases

INFECTIOUS DISEASES

A WEALTH OF TESTING EXPERIENCE

BioPharma Diagnostics offers access to the infectious disease testing capabilities of Mayo Clinic’s internationally renowned clinical microbiology laboratories. With more than 70 years of testing experience, our laboratories span all areas of conventional and molecular medical microbiology, offering a broad selection of tests designed for rapid identification and in-depth characterization of the bacterial, viral, fungal, and parasitic agents of infectious diseases.

Performing more than four million tests annually, our seven clinical microbiology laboratories have developed and implemented in vitro and culture techniques, immunoassays, antimicrobial susceptibility testing, and molecular methods for rapid detection, identification, and characterization of microbial pathogens.

Our laboratories are managed by physician-scientists, many of whom are actively engaged in clinical practice and research. Through BioPharma Diagnostics, our partners have access to a wealth of world-renowned expertise to help guide test ordering and interpret results.

To learn more about our testing, view our biopharma-specific test catalog and full test catalog.

Test menu

Full suite of infectious disease testing Full suite of infectious disease testing
Full suite of infectious disease testing

Our internationally renowned clinical microbiology laboratories offer a broad selection of tests designed for rapid identification and in-depth characterization of the causative agents of infectious diseases. We have developed and implemented culture techniques, immunoassays, antimicrobial susceptibility testing, and molecular methods for rapid detection, identification, and characterization, as well as provision treatment guidance for microbial pathogens.

Fungal infections Fungal infections
Fungal infections

Our comprehensive fungal infection testing menu is supported by ongoing innovation and development of novel testing methods and strategies and enable detection of a wide range of clinically significant pathogens, including newly emerging species.

Helicobacter pylori Helicobacter pylori
Helicobacter pylori

Find out why timely, accurate diagnosis of H. pylori is critical for improving patients’ gastrointestinal health and preventing further harm.

Infectious disease pathology Infectious disease pathology
Infectious disease pathology

Our practice provides regular exposure, not only to the common infections, but also to uncommon infections that most pathologists may only see once in their careers.

Vector-borne diseases Vector-borne diseases
Vector-borne diseases

Our internationally renowned clinical microbiology laboratories span all areas of conventional, molecular, and serological medical microbiology, offering a broad selection of tests designed for rapid identification and in-depth characterization of the pathogens associated with infectious diseases.

Comprehensive disease testing

Through BioPharma Diagnostics, our partners have access to Mayo Clinic Laboratories’ infectious disease test catalog, including testing for:

  • Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
  • Helicobacter pylori
  • Infectious disease pathology
  • Vector-borne diseases
  • HIV and hepatitis

Our molecular testing methods include:

  • Polymerase chain reaction (PCR) testing
  • Advanced whole genome microbial sequencing
  • Targeted metagenomic sequencing
  • Matrix-assisted laser-desorption/ionization-time of flight (MALDI-TOF) mass spectrometry organism identification

In addition to using clinically available testing, BioPharma Diagnostics partners can access infectious disease testing for clinical trials and be among the first to use up-and-coming tests currently in development.

News and updates

The latest

Dr. Morice discusses lab market trends with the Advisory Board

William Morice II, M.D., Ph.D., recently joined the Advisory Board for a webinar discussion on 2024 lab market trends. Dr. Morice covered the current lab market outlook, the priority trends, and opportunities for future growth.

Learn more
When to test for norovirus: Dr. Bill Morice

In this episode of “Answers From the Lab,” host and William Morice II, M.D., Ph.D., discuss what’s causing recent outbreaks of norovirus and how to keep yourself protected from this leading cause of foodborne illness in the United States.

Dr. Robin Patel shares periprosthetic joint infection findings in NEJM

The New England Journal of Medicine recently published new findings on periprosthetic joint infection by Dr. Robin Patel.

Recap of this year’s J.P. Morgan Healthcare Conference and COVID-19 update: Dr. Bill Morice

William Morice II, M.D., Ph.D., president and CEO of Mayo Clinic Laboratories, joins “Answers From the Lab” for his weekly leadership update with host Bobbi Pritt, M.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic. In this episode, Dr. Morice shares his biggest takeaways from this year’s J.P. Morgan Healthcare Conference in San Francisco, California, and gives an update on the COVID-19 public health emergency.  

Respiratory virus update and a new measles test: Dr. Matthew Binnicker

Matthew Binnicker, Ph.D., director of the Clinical Virology Laboratory at Mayo Clinic, joins host Bobbi Pritt, M.D., on this week’s episode of the "Answers From the Lab" podcast. In this episode, they discuss the ongoing respiratory virus season, a new test for measles available at Mayo Clinic Laboratories, and some tips to stay healthy.

Robin Patel, M.D., and team study the use of transcriptomic-based cellular deconvolution to identify infectious and non-infectious causes of failed joint replacement surgeries 

New research by Robin Patel, M.D. and others at Mayo Clinic has found that the use of a “transcriptomic-based cellular deconvolution tool” called CIBERSORTx could help improve the detection of infectious and non-infectious causes of failed joint replacement surgeries.

Monkeypox and legislation updates: Dr. Bill Morice

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins "Answers From the Lab" for his weekly leadership update with host Bobbi Pritt, M.D. In this episode, Dr. Pritt and Dr. Morice discuss the latest monkeypox developments, potential scenarios for monkeypox moving forward, and where the VALID Act stands.

Syndromic Testing for Infectious Diseases: Multiplex Panels for Positive Blood Culture Bottles

In this month's "Hot Topic," Robin Patel, M.D., discusses how the use of multiplex tests may reduce the turnaround time for identifying the cause of bloodstream infections, and how this might impact antibiotic stewardship and patient outcomes.

Syndromic Testing for Infectious Diseases: Respiratory Infections

In this month's "Hot Topic," Matthew Binnicker, Ph.D., discusses the use of multiplex panels for the diagnosis of respiratory infections and focuses on the clinical utility of these tests in the setting of upper respiratory tract infections.

Clinical microbiology at Mayo Clinic: A look back and ahead

The field of clinical microbiology has a long and distinguished history at Mayo Clinic. Since the early 1900s, the clinical microbiology team has played important and leading roles in advancing testing and patient care.

Viruses and Variants: Dr. Bill Morice

William Morice II, M.D., Ph.D., chair of the Department of Laboratory Medicine and Pathology at Mayo Clinic and president of Mayo Clinic Laboratories, joins the "Answers From the Lab" podcast for his weekly leadership update with Bobbi Pritt, M.D. In this episode, Dr. Morice and Dr. Pritt discuss the range of emerging viruses and their variants that are currently in the news.

Recent Outbreaks of Viral Infections: Dr. Matt Binnicker

Matthew Binnicker, Ph.D., director of Mayo Clinic’s Clinical Virology Laboratory, joins the "Answers From the Lab" podcast for a discussion with Bobbi Pritt, M.D. about recent outbreaks of viral infections. In this episode, Dr. Binnicker and Dr. Pritt look at the hepatitis cases in children possibly linked to adenovirus as well as the spread of Monkeypox.

Tick-borne Disease Testing: Elitza Theel, Ph.D.

Elitza Theel, Ph.D., director of the Infectious Diseases Serology Lab at Mayo Clinic, joins the "Answers From the Lab" podcast for a discussion with Bobbi Pritt, M.D. about tick-borne disease testing. In this episode, Dr. Theel and Dr. Pritt look at emerging tick-borne illnesses, the tests available to detect these infections, and how to prevent them.

View More
INTERESTED IN LEARNING MORE?

Fill out the form below and one of our specialists will be in touch.

Are you a patient? Click here.